Apr 30, 2020Microbiome after coronavirus: Investing in the power of microbesThe Microbiome Times published Sandwalk’s analysis of how the coronavirus pandemic may affect the field of microbiome-based drugs...
Apr 15, 2020Regulatory framework for food supplements in Europe and the new Mutual Recognition RegulationOn April 19th, 2020, the new Mutual Recognition Regulation 2019/515 (1) will apply. Mutual recognition is a principle derived from the...
Apr 10, 2020Fourth Safety Alert of FDA on FMT in less than a monthThe FDA updates the safety measures for FMT precautions related to SARS-CoV-2 it established on March 23, 2020. This warning comes after...
Apr 8, 2020FDA issues new safety alert on FMT - third one in less than a monthThe FDA has issued a new safety alert on Fecal Transplant (FMT), a type of microbiome therapy, by which the Administration establishes...
Apr 5, 2020Sandwalk to present at the 2nd Experts Meeting on Microbial Strain Safety Assessment for RegulatorySandwalk’s Managing Director Dr. Luis Gosalbez, will present Bringing novel microbes to market: Regulatory intelligence for current and...
Mar 30, 2020Sandwalk licenses its Microbiome Drug Database™ to The Microbiome TimesSandwalk has signed an agreement with The Microbiome Times (http://www.microbiometimes.com/), one of the most respected papers in the...
